Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NC318
NC318
NextCure Delays 2 Clinical Trials Due to Coronavirus
Motley Fool
Tue, 04/14/20 - 09:57 pm
NextCure
clinical trials
COVID-19
pandemic
immuno-oncology
NC318
NC410
Early data on NextCure's immuno-oncology drug in lung cancer patients delights investors
Endpoints
Thu, 11/7/19 - 10:18 am
NextCure
immuno-oncology
NC318
Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO
Mon, 04/29/19 - 10:04 am
NextCure
NC318
immuno-oncology
Fresh from Eli Lilly deal, NextCure bags $93M for clinical push
Fierce Biotech
Tue, 11/13/18 - 09:58 am
NextCure
NC318
Eli Lilly